LWW Oncology | Search

Showing Results for chemoprevention

Narrow Results

Topics

All Topics (41)

bladder cancer (2)

brca1/2 carriers and (1)

breast cancer (4)

breast cancer (2)

carotenoids and (1)

cervical cancer and (1)

classification (1)

clinical trials (2)

colorectal cancer and (1)

combination therapy and (1)

definition (4)

dna methylation and (1)

drug development and (1)

efficacy (1)

elderly patients and (1)

esophageal cancer and (1)

familial breast cancer and (1)

gastric cancer and (1)

goals (1)

head and neck cancer and (1)

lobular carcinoma in situ of the breast and (1)

lung cancer (3)

mechanism of action (1)

micronutrients and (1)

ovarian cancer (1)

population benefits (1)

prostate cancer (2)

retinoids and (1)

skin cancer and (1)

techniques (1)

Content Types

All (41)

Texts (41)

NCI Clinical Trials

Looking for trials? Go to NCI and browse 8,000+ trials

41 Search Results

Principles & Practice of Lung Cancer

Chapter 21. Molecular Carcinogenesis and Chemoprevention of Lung Cancer

Cancer: Principles & Practice of Oncology

Chapter 54. Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention

Cancer: Principles & Practice of Oncology

Chapter 55. Drugs and Nutritional Extracts for Cancer Risk Reduction (Chemoprevention)

Diseases of the Breast

Chapter 22. Chemoprevention: Clinical Aspects

Principles & Practice of Lung Cancer

Chapter 15. Population-Based Lung Cancer Prevention: An Overview >

Chemoprevention

Lung cancer, like many other cancers, appears to be the final consequence of dysregulation involving varied pathways. However, this results in a common “phenotypic” outcome. Population-based lung cancer screening has ...

Principles & Practice of Lung Cancer

Chapter 15. Population-Based Lung Cancer Prevention: An Overview >

Chemoprevention Strategies

Experimental work in rodents suggests that specific drugs can mitigate the progressive development of lung neoplasias after the exposure to specific tobacco-carcinogen exposures.57,58 Additional impetus arises from the clinical experience ...

Principles & Practice of Lung Cancer

Chapter 21. Molecular Carcinogenesis and Chemoprevention of Lung Cancer >

Clinical Chemoprevention Trials

Laudable as smoking cessation efforts have been, it is clear that lung cancers are developing in former smokers.42,43 Thus, the design of lung cancer trials has taken the approach to ...

Cancer: Principles & Practice of Oncology

Chapter 53. Principles of Cancer Risk Reductive Intervention >

Defining Cancer Risk Reductive Intervention (Chemoprevention)

Cancer risk reductive intervention, commonly referred to as chemoprevention, is the use of a range of interventions from purified drugs to purified dietary extracts to dietary modulation to block, reverse, ...

Cancer: Principles & Practice of Oncology

Chapter 53. Principles of Cancer Risk Reductive Intervention >

Identifying Potential Cancer Risk Reductive Interventions

Cancer risk reductive interventions (CRRIs) result from the synthesis of data from population, basic, translational, and clinical sciences. Data sets from all of these disciplines are combined to contribute to ...

Cancer: Principles & Practice of Oncology

Chapter 53. Principles of Cancer Risk Reductive Intervention >

Preclinical Development of Cancer Risk Reductive Interventions

Similar to the development of therapeutic interventions, assessment of efficacy and toxicity of single chemically synthesized entities, agents designed in silico, botanicals, purified nutritional extracts, and nutritional supplements for cancer ...

Cancer: Principles & Practice of Oncology

Chapter 53. Principles of Cancer Risk Reductive Intervention >

Clinical Development of Cancer Risk Reductive Interventions

Cancer: Principles & Practice of Oncology

Chapter 54. Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention >

Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention: Introduction

Cancer chemoprevention can be defined as pharmacologic intervention with specific nutrients or other chemicals to suppress or reverse carcinogenesis and to prevent the development of invasive cancer.1 Two basic concepts ...

Cancer: Principles & Practice of Oncology

Chapter 54. Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention >

Head and Neck Cancer Chemoprevention

Squamous cell carcinomas of the head and neck have been a model for chemoprevention research involving micronutrients for decades. This particular organ site has many advantages for prevention research purposes: ...

Cancer: Principles & Practice of Oncology

Chapter 54. Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention >

Lung Cancer Chemoprevention

Cancer: Principles & Practice of Oncology

Chapter 54. Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention >

Breast Cancer Chemoprevention

Moon et al.45 first showed that fenretinide was a promising cancer chemopreventive agent for the breast, having a high therapeutic index and synergistic interaction with tamoxifen in mammary carcinogenesis model ...

Cancer: Principles & Practice of Oncology

Chapter 54. Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention >

Skin Cancer Chemoprevention

Data suggest that topical all-trans-retinoic acid (ATRA) has significant dose-related activity in reversing premalignant skin lesions (e.g., actinic keratoses, which undergo a malignant transformation rate of 5%).59 Systemic retinoid therapy ...

Cancer: Principles & Practice of Oncology

Chapter 54. Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention >

Bladder Cancer Chemoprevention

Three randomized clinical trials have tested the retinoid etretinate in patients following resection of their superficial (noninvasive) bladder tumors, which recur in 40% to 90% of cases. All three studies ...

Cancer: Principles & Practice of Oncology

Chapter 54. Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention >

Cervical Cancer Chemoprevention

Many randomized and nonrandomized chemoprevention studies have been conducted in cervical dysplasia. Randomized trials include two studies of folic acid, four of interferons, four of α-carotene, and five of retinoids. ...

Cancer: Principles & Practice of Oncology

Chapter 54. Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention >

Esophageal/Gastric Cancer Chemoprevention

Certain regions of China (Huixian and Linxian) have strikingly high incidence rates of esophageal and gastric cancers; moreover, intake and blood levels of various micronutrients are consistently low in these ...

Cancer: Principles & Practice of Oncology

Chapter 54. Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention >

Colorectal Cancer Chemoprevention

Several randomized trials aimed at the prevention of recurrent colorectal adenomas with micronutrients have been completed. Beginning with supplemental α-carotene, the Australian Polyp Prevention Project evaluated the efficacy of reducing ...

Cancer: Principles & Practice of Oncology

Chapter 54. Retinoids, Carotenoids, and Other Micronutrients in Cancer Prevention >

Prostate Cancer Chemoprevention

Recent evidence suggests that oxidative stress may play a role in the etiology of prostate cancer, and several antioxidant nutrients including lycopene, vitamin E, and selenium have been of interest ...

Cancer: Principles & Practice of Oncology

Chapter 55. Drugs and Nutritional Extracts for Cancer Risk Reduction (Chemoprevention) >

Multiagent Chemoprevention

In the transition to molecular-targeted interventions, combinations of targets that logically address critical carcinogenesis pathways may have greater efficacy than single agents. For example, interactive signaling of epidermal growth factor ...

Cancer: Principles & Practice of Oncology

Chapter 72. Treatment of Head and Neck Cancer >

Chemoprevention

Chemoprevention is the administration of natural or synthetic agents to reduce the risk of developing SPTs. Patients who have a head and neck SCC have an increased risk of developing ...

Cancer: Principles & Practice of Oncology

Chapter 75. Non–Small Cell Lung Cancer >

Chemoprevention

Despite encouraging preclinical data, the results of large chemoprevention trials evaluating primary prevention (healthy high-risk smokers), secondary prevention (premalignant lesions), and tertiary prevention (second primary tumors in previously treated individuals) ...

Principles and Practice of Gynecologic Oncology

Chapter 29. Breast Cancer >

Prevention

Cancer Chemotherapy and Biotherapy: Principles and Practice

Chapter 36. Hormone Therapy for Prostate Cancer >

Chemoprevention of Prostate Cancer

Prostate cancer is the most common malignancy for men in the United States, with an estimated 192,280 new diagnoses in 2009.43 Strategies for prostate cancer prevention in healthy men are ...

Perez and Brady’s Principles and Practice of Radiation Oncology

Chapter 53. Early Stage Breast Cancer >

Tamoxifen

Understanding of the role of estrogen and progesterone in breast cancer development has led to the development of pharmacologic strategies that could significantly decrease the incidence of breast cancer over ...

Diseases of the Breast

Chapter 19. Genetic Testing and Management of Patients with Hereditary Breast Cancer >

Chemoprevention

Data from the NSABP P1 Breast Cancer Prevention Trial, the International Breast Cancer Intervention Study (IBIS-I), and the Study of Tamoxifen and Raloxifene (STAR) demonstrate that 5 years of the ...

Diseases of the Breast

Chapter 19. Genetic Testing and Management of Patients with Hereditary Breast Cancer >

Chemoprevention

Oral contraceptives are known to decrease the risk of ovarian cancer in the general population (223). As discussed previously, in the section on cancer risk modifiers, a recently published large ...

Diseases of the Breast

Chapter 19. Genetic Testing and Management of Patients with Hereditary Breast Cancer >

Chemoprevention

Another important decision for mutation carriers concerns whether to utilize chemopreventive agents. As yet, however, few data exist regarding the utilization of chemopreventive agents or participation in chemoprevention trials among ...

Diseases of the Breast

Chapter 22. Chemoprevention: Clinical Aspects >

Population Benefits Of Chemoprevention

Of the more than 65 million women aged 35 to 79 years without reported breast cancer in the United States in 2000, more than 10 million women would be eligible ...

Diseases of the Breast

Chapter 22. Chemoprevention: Clinical Aspects >

Management Summary

Diseases of the Breast

Chapter 25. Lobular Carcinoma In Situ: Clinical Management >

Chemoprevention

Two large trials have been conducted by the National Surgical Adjuvant Breast and Bowel Project (NSABP) to address the use of chemoprevention for risk reduction in women with increased risk ...

Diseases of the Breast

Chapter 91. Breast Cancer in Older Women >

Prevention

Chemoprevention of breast cancer is reviewed in Chapter 22. The selective estrogen receptor modulators (SERM), tamoxifen and raloxifene, decrease the incidence of breast cancer, with differential benefit in decreasing hormone ...

Principles and Practice of Pediatric Oncology

Chapter 54. Preventing Cancer in Adulthood: Advice for the Pediatrician >

Chemoprevention

A multibillion dollar industry has developed for chemopreventive agents that are intended to inhibit, delay, or reverse carcinogenesis. These agents include many classes of compounds such as antioxidants including both ...

Principles of Molecular Diagnostics and Personalized Cancer Medicine

Chapter 16. DNA Hypermethylation in Cancer >

DNA Methylation as a Target for Cancer Chemoprevention and Treatment

The fundamental difference between genetic alterations and epigenetic changes is that the former are irreversible and the latter are potentially reversible. The potential reversibility of epigenetic changes in neoplasia presents ...

Comprehensive Textbook of Genitourinary Oncology, 4e

Chapter 18. Screening, Early Detection, and Prevention of Bladder Cancer >

Chemoprevention

The ideal chemopreventive agent must be well tolerated, inexpensive, readily available, and have an acceptable toxicity profile. Ideally, it would also have some efficacy in treatment of the disease. Newer ...

Principles & Practice of Lung Cancer

Chapter 15. Population-Based Lung Cancer Prevention: An Overview > Chemoprevention

The term chemoprevention was introduced by Sporn et al.55 in ...

Cancer: Principles & Practice of Oncology

Chapter 104. Ovarian Cancer, Fallopian Tube Carcinoma, and Peritoneal Carcinoma > Hereditary Ovarian Carcinoma

It has been suggested that chemoprophylaxis with oral contraceptives for ...

Perez and Brady’s Principles and Practice of Radiation Oncology

Chapter 1. The Discipline of Radiation Oncology > Cancer Prevention

Cancer chemoprevention is defined as a pharmacologic intervention with specific ...

Diseases of the Breast

Chapter 22. Chemoprevention: Clinical Aspects > Introduction

Chemoprevention can be defined as the use of specific natural ...